Back
PMC - Vaccine Development Partnerships
paperPubMed Central(peer-reviewed)·pmc.ncbi.nlm.nih.gov/articles/PMC7108492/
Author
Qiuyang Wu
Credibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: PubMed Central
This biomedical/public health paper on vaccine development partnerships has limited direct relevance to AI safety, though its coordination and governance models for public-private partnerships may offer tangential lessons for AI governance discussions.
Metadata
Importance: 12/100journal articleanalysis
Summary
This paper examines partnership models in vaccine development, analyzing how public and private sector entities collaborate to accelerate the development and deployment of vaccines. It explores coordination mechanisms, funding structures, and governance frameworks that enable successful vaccine research and production at scale.
Key Points
- •Analyzes public-private partnership models for vaccine development and their effectiveness in accelerating research timelines
- •Examines governance and coordination challenges when multiple stakeholders collaborate on large-scale health interventions
- •Explores funding mechanisms and incentive structures that align public health goals with private sector participation
- •Discusses lessons learned from historical vaccine development partnerships applicable to future pandemic preparedness
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Organization | 53.0 |
Cached Content Preview
HTTP 200Fetched Mar 15, 202635 KB
CEPI: Driving Progress Toward Epidemic Preparedness and Response - PMC
Skip to main content
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
Lock
Locked padlock icon
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Search PMC Full-Text Archive
Search in PMC
Journal List
User Guide
PERMALINK
Copy
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
Epidemiol Rev . 2019 Nov 1;41(1):28–33. doi: 10.1093/epirev/mxz012
CEPI: Driving Progress Toward Epidemic Preparedness and Response
Dimitrios Gouglas
Dimitrios Gouglas
Find articles by Dimitrios Gouglas
✉ , Mario Christodoulou
Mario Christodoulou
Find articles by Mario Christodoulou
, Stanley A Plotkin
Stanley A Plotkin
Find articles by Stanley A Plotkin
, Richard Hatchett
Richard Hatchett
Find articles by Richard Hatchett
Author information
Article notes
Copyright and License information
✉ Correspondence to Dimitrios Gouglas, Coalition for Epidemic Preparedness Innovation (CEPI), PO Box 123, Torshov, 0412 Oslo, Norway (e-mail: Dimitrios.gouglas@cepi.net ).
Received 2018 Dec 4; Revised 2019 Sep 23; Accepted 2019 Sep 24; Collection date 2019.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
PMC Copyright notice
PMCID: PMC7108492 PMID: 31673694
Abstract
The Coalition for Epidemic Preparedness Innovations (CEPI) was formed in the aftermath of the 2014–2015 Ebola outbreak in west Africa to support the development of vaccines that could improve the world’s preparedness against outbreaks of epidemic infectious diseases. Since its launch in 2017, CEPI has mobilized more than US$750 million to support its missi
... (truncated, 35 KB total)Resource ID:
13ae956667716d8f | Stable ID: OTg2ZTEzYT